← All trials
NCT05116215
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 13, 2021
- Primary completion
- Aug 12, 2022
- Completion date
- Aug 12, 2022
- First posted
- Nov 10, 2021
- Last posted
- Nov 10, 2021
- Enrollment
- 27
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- HoHo BiotechLead sponsor
- Government of TaiwanCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.